ENvue Medical, Inc. (FEED)

Market Cap	3.33M -21.9%
Revenue (ttm)	1.93M -17.7%
Net Income	-49.19M
EPS	-206.88
Shares Out	923.72K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,643
Open	3.630
Previous Close	3.570
Day's Range	3.540 - 3.630
52-Week Range	3.480 - 208.800
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 17, 2026

About FEED

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is desig...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: FEED
• Website: https://envuemed.com

Financial Performance

In 2025, ENvue Medical's revenue was $2.55 million, a decrease of -0.20% compared to the previous year's $2.56 million. Losses were -$16.78 million, 352.8% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 11, 2026

Data Sources Report a data error